Skip to main content
. 2021 Mar 31;61(1):319–330. doi: 10.1093/rheumatology/keab325

Table 2.

Pulmonary manifestations in patients with different forms of vasculitis

TAK GCA GPA MPA EGPA PAN IgAV
Clinical features, patients (%)
 Any respiratory symptom 37 (21.8) 104 (15.8) 358 (64.5) 147 (65.9) 130 (89.0) 13 (27.1) 9 (5.9)
 Dyspnoea 25 (14.7) 51 (7.8) 232 (41.8) 97 (43.5) 96 (65.8) 9 (18.8) 4 (2.6)
 Any cough 13 (7.6) 61 (9.3) 193 (34.8) 84 (37.7) 81 (55.5) 8 (16.7) 5 (3.3)
 Dry cough 11 (6.5) 54 (8.2) 133 (24.0) 48 (21.5) 50 (34.2) 5 (10.4) 4 (2.6)
 Productive cough 2 (1.2) 7 (1.1) 60 (10.8) 36 (16.1) 31 (21.2) 3 (6.3) 1 (0.7)
 Haemoptysis 3 (1.8) a 2 (0.3)a 148 (26.7) 52 (23.3) 12 (8.2) 2 (4.2) 0
 Pleuritic chest pain 3 (1.8) 6 (0.9) 43 (7.7) 13 (5.8) 7 (4.8) 2 (4.2) 0
 Chest wall tenderness 1 (0.6) 1 (0.2) 10 (1.8) 1 (0.4) 3 (2.1) 0 0
 Crackles on auscultation 2 (1.2) 10 (1.5)b 89 (16.0) 69 (30.9) 21 (14.4) 3 (6.3) 1 (0.7)
 Wheezing on auscultation 2 (1.2) 7 (1.1) 24 (4.3) 13 (5.8) 79 (54.1) 0 2 (1.3)
 Oxygen administered 2 (1.2) 1 (0.2) 44 (7.9) 32 (14.3) 14 (9.6) 3 (6.3) 1 (0.7)
 Mechanical ventilation 0 0 15 (2.7) 6 (2.7) 5 (3.4) 0 0
Imaging findings, patients (%)
 Pulmonary imaging available 73 (42.9) 380 (57.8) 476 (85.8) 197 (88.3) 127 (87.0) 28 (58.3) 82 (53.6)
 Normal imaging 64 (87.7) 309 (81.3) 197 (41.4) 54 (27.4) 38 (30.0) 18 (64.3) 73 (89.0)
 Inflammation 2 (2.8) 12 (5.0) 65 (13.7) 46 (23.4) 39 (30.7) 0 1 (1.2)
 Haemorrhage 0 0 30 (6.3) 19 (9.6) 1 (0.8) 1 (3.6) 0
 Nodules 2 (2.8) 13 (3.4) 119 (25.0)c 23 (11.7) 17 (13.4) 0 1 (1.2)
 Mass 0 1 47 (9.9) 0 0 0 0
 Abscess 0 0 8 (1.7) 0 0 0 1 (1.2)
 Consolidation 1 (1.4) 1 76 (16.0) 40 (20.3) 33 (26.0) 5 (17.9) 3 (3.7)
 Fibrosis 0 6 (1.6) 9 (1.9) 49 (24.9) 8 (6.3) 0 1 (1.2)
 Effusion 0 9 (2.3) 37 (7.8) 27 (13.7) 13 (10.2) 3 (10.7) 1 (1.2)
a

In the 3 patients with TAK and 2 patients with GCA with haemoptysis, a previous history of COPD, smoking, congestive heart failure or productive cough was documented. bTen patients with GCA had crackles on lung auscultation, with 7 of them being current or previous smokers, 2 having chronic obstructive pulmonary disease (COPD) and 3 having a positive test for pANCA. Out of these 10 patients, 7 had normal lung imaging, while 3 patients had fibrosis or atelectasis. cClinical haemoptysis was reported by 36% of patients with GPA and pulmonary nodules. TAK: Takayasu’s arteritis; GPA: granulomatosis with polyangiitis; MPA: microscopic polyangiitis; EGPA: eosinophilic GPA; PAN: polyarteritis nodosa; IgAV: IgA vasculitis.